All Posts
CCF Funding Part of Important Study and Publication
Nabeel M. Bardeesy, PhD is the John R. Gallagher III and Katherine A. Gallagher Endowed Chair in Gastrointestinal Cancer Research…
Cholangiocarcinoma SURVIVOR
By Kathi and Andrew Dyal Andrew and I attended the same high school in LaGrangeville, NY. We ran in the…
Celebrating Seven Years of CholangioConnect
A Vision Takes Shape In the complex and often isolating world of cholangiocarcinoma, the CholangioConnect program emerged seven years ago…
Hope and Gratitude, One Step at a Time
by Heather Black, with contributions from Joan and Johanna Memorial Day 2024 in Boulder, Colorado, was a perfect day of…
De's 0.9 Mile Marathon Celebrates Community
On Saturday, June 1st, 2024, the streets of Baltimore, Maryland, came alive with celebration and remembrance as the second annual…
A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Solid Tumors
Study Name A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Solid Tumors…
The 5th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer
The 5th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer was held May 18th at Midnight Oil…
A Phase I, Dose Escalation Safety and Tolerability Study of VAXINIA (CF33-hNIS), Administered Intratumorally or Intravenously as a Monotherapy or in Combination with Pembrolizumab in Adult Patients with Metastatic or Advanced Solid Tumors (MAST).
Study Name A Phase I, Dose Escalation Safety and Tolerability Study of VAXINIA (CF33-hNIS), Administered Intratumorally or Intravenously as a Monotherapy…
Honoring A Legacy: The Laura Dye Tie Challenge at American Preparatory Academy
WEST VALLEY CITY, UTAH - The American Preparatory Academy-West Valley 1 campus in West Valley City came together to honor…
The Fifth Annual Quack Out Cholangio 5K Run/Walk Raises Funds for Rare Cancer Research
NEWARK, DELAWARE – The 5th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer was held May 18th…